In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus

Zika virus (ZIKV) causes significant human diseases without specific therapy. Previously we found erythrosin B, an FDA-approved food additive, inhibited viral NS2B−NS3 interactions, leading to inhibition of ZIKV infection in cell culture. In this study, we performed pharmacokinetic and in vivo studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhong, Xu, Jimin, Lang, Yuekun, Wu, Xiangmeng, Hu, Saiyang, Samrat, Subodh Kumar, Tharappel, Anil M., Kuo, Lili, Butler, David, Song, Yongcheng, Zhang, Qing-Yu, Zhou, Jia, Li, Hongmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279632/
https://www.ncbi.nlm.nih.gov/pubmed/35847519
http://dx.doi.org/10.1016/j.apsb.2021.10.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279632/
https://www.ncbi.nlm.nih.gov/pubmed/35847519
http://dx.doi.org/10.1016/j.apsb.2021.10.017

Ejemplares similares